A PHASE-II TRIAL OF INTERMITTENT LEUKOCYTE INTERFERON AND HIGH-DOSE CHLORAMBUCIL IN THE TREATMENT OF NON-HODGKINS LYMPHOMA RESISTANT TO CONVENTIONAL THERAPY

被引：15

作者：

CLARK, RH

DIMITROV, NV

AXELSON, JA

CHARAMELLA, LJ

STOTT, PB

机构：

[1] MICHIGAN STATE UNIV,CANC TREATMENT CONSORTIUM,E LANSING,MI 48824

[2] MICHIGAN DEPT PUBL HLTH,LANSING,MI 48909

来源：

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 1989年 / 12卷 / 01期

关键词：

D O I：

10.1097/00000421-198902000-00017

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：75 / 77

页数：3

共 16 条

[11] PRELIMINARY-OBSERVATIONS ON EFFECT OF HUMAN LEUKOCYTE INTERFERON IN NON-HODGKINS LYMPHOMA [J].

MERIGAN, TC ;

SIKORA, K ;

BREEDEN, JH ;

LEVY, R ;

ROSENBERG, SA .

NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (26) :1449-1453

[12] A PHASE-I TRIAL OF RECOMBINANT LEUKOCYTE ALPHA-2 INTERFERON IN PATIENTS WITH ADVANCED MALIGNANCY [J].

MUSS, HB ;

HOMESLEY, HD ;

RUDNICK, SA ;

PLUNKETT, S ;

CAPONERA, M ;

COOPER, MR ;

JACKSON, DV ;

JOBSON, VN ;

RICHARDS, F ;

SPURR, CL ;

STUART, JJ ;

WELANDER, C ;

WHITE, DR ;

FERRARESI, RL ;

NORRED, S .

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1985, 8 (02) :97-107

[13]

RAPSON CR, 1983, BLOOD S1, V62, pA214

[14]

SLATER LM, 1981, CANCER, V48, P5, DOI 10.1002/1097-0142(19810701)48:1<5::AID-CNCR2820480103>3.0.CO

[15]

2-C

[16]

SOLMON SE, 1983, J BIOL RESP MODIF, V2, P207

← 1 2 →